MedPath

OrthoPulse 2.0 and 2.1 Feasibility Evaluation

Not Applicable
Conditions
Malocclusion
Interventions
Device: OrthoPulse 2.0
Device: OrthoPulse 2.1
Device: Fixed Orthodontic Appliances (Braces)
Device: Invisalign 3.5 Day Wear
Registration Number
NCT03683017
Lead Sponsor
Biolux Research Holdings, Inc.
Brief Summary

OrthoPulse is a device that uses near-infrared light therapy in order to decrease orthodontic treatment time. The aim of this study is to evaluate OrthoPulse products modified with extended arrays, OrthoPulse 2.0 and OrthoPulse 2.1, and to assess their clinical effectiveness.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Written Informed Consent must be obtained before any assessment is performed
  • Patient must be 11 years of age or older; minors will only be included in the study with the consent of the Parent/Legal Authorized Representative (LAR)
  • Presence of permanent dentition
  • Eligible and scheduled for full mouth fixed orthodontic treatment or Invisalign
  • Good oral hygiene
  • Likely to be compliant to OrthoPulse 2.0 and 2.1 use, aligner wear and elastic wear
  • Have a compatible iOS or Android device and are willing to download the OrthoPulse app for frequent automatic syncing of use data
Exclusion Criteria
  • Patient is currently enrolled in another clinical study
  • Periodontally involved teeth, acute oral infection or periodontal disease
  • Use of bisphosphonates (osteoporosis drugs) during the study
  • Use of drugs that may cause photosensitivity
  • History of photosensitivity
  • History of poor oral hygiene, per the discretion of the Principal Investigator (PI)
  • Epilepsy
  • Patient plans to relocate over the treatment period
  • Smoker or use of any tobacco containing products per the discretion of the PI

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
I-OP2.0OrthoPulse 2.0Patients receive Invisalign orthodontic treatment, with 3.5 day Aligner changes, by the qualified Principal Investigator (PI). Patients receive OrthoPulse 2.0 device.
F-OP2.0Fixed Orthodontic Appliances (Braces)Patients receive fixed appliance orthodontic treatment by the qualified Principal Investigator (PI). Patients receive OrthoPulse 2.0 device.
I-OP2.1OrthoPulse 2.1Patients receive Invisalign orthodontic treatment, with 3.5 day Aligner changes, by the qualified Principal Investigator (PI). Patients receive OrthoPulse 2.1 device.
I-OP2.0Invisalign 3.5 Day WearPatients receive Invisalign orthodontic treatment, with 3.5 day Aligner changes, by the qualified Principal Investigator (PI). Patients receive OrthoPulse 2.0 device.
I-OP2.1Invisalign 3.5 Day WearPatients receive Invisalign orthodontic treatment, with 3.5 day Aligner changes, by the qualified Principal Investigator (PI). Patients receive OrthoPulse 2.1 device.
F-OP2.0OrthoPulse 2.0Patients receive fixed appliance orthodontic treatment by the qualified Principal Investigator (PI). Patients receive OrthoPulse 2.0 device.
Primary Outcome Measures
NameTimeMethod
Feedback on general experienceThrough Study Completion, approx. 2 years

Assess doctor and patient feedback on the general experience with OrthoPulse 2.0 and OrthoPulse 2.1 as measured in the electronic data capture system.

Feedback on clinical performanceThrough Study Completion, approx. 2 years

Assess doctor subjective and objective feedback on the clinical performance of OrthoPulse 2.0 and OrthoPulse 2.1 as measured in the electronic data capture system.

Adverse eventsThrough Study Completion, approx. 2 years

Confirm initial safety of OrthoPulse 2.0 and OrthoPulse 2.1

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Bella Smile

🇺🇸

San Francisco, California, United States

Dickerson Orthodontics

🇺🇸

Scottsdale, Arizona, United States

Sphinx Orthodontics

🇨🇦

Edmonton, Alberta, Canada

Chenin Orthodontics

🇺🇸

Henderson, Nevada, United States

© Copyright 2025. All Rights Reserved by MedPath